Samsung Biologics investing $736 mln in manufacturing plant

November 27, 2015 11:07 AM

22 0

SEOUL Nov 27 Samsung Biologics, an unlisted arm of South Korea's Samsung Group, said on Friday it would invest 850 billion won ($736 million) to build a manufacturing facility, as the conglomerate steps up its expansion in the biopharmaceutical sector.

Construction of the plant, which will have a capacity of 180,000 litres, is to be completed by September 2018, according to a regulatory filing.

Read more

To category page